Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v6-EN Version v5-FR
Language English French
Date Updated 2023-03-17 2023-03-08
Drug Identification Number 02329093 02329093
Brand name INDIUM DTPA IN 111 INDIUM DTPA IN 111
Common or Proper name Pentetate Indium Disodium In 111 Injection Pentetate Indium Disodium In 111 Injection
Company Name GE HEALTHCARE CANADA INC GE HEALTHCARE CANADA INC
Ingredients PENTETATE INDIUM DISODIUM IN 111 PENTETATE INDIUM DISODIUM IN 111
Strength(s) 37MBq 37MBq
Dosage form(s) SOLUTION SOLUTION
Route of administration INTRATHECAL INTRATHECAL INTRATHECAL INTRATHECAL
Packaging size 1.5 mL 1.5 mL
ATC code V09AX V09AX
ATC description
Reason for shortage Other (Please describe in comments) Other (Please describe in comments)
Anticipated start date
Actual start date 2023-03-03 2023-03-03
Estimated end date 2023-03-17 2023-03-17
Actual end date 2023-03-17
Shortage status Actual shortage Actual shortage
Tier 3 Status No No
Company comments Manufacturing issues Manufacturing issues
Health Canada comments